A Prospective Multi-center Randomized Clinical Trial to Compare Survival Rates and Quality of Life According to Follow-up Period in Patients Who Underwent Radical Gastrectomy for Advanced Gastric Cancer (STOFOLUP Trial)

Status: Recruiting
Location: See all (16) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is a multi-center, prospective, randomized controlled study. The aim of this study is to compare survival rates and to observe quality of life and nutritional status according to follow-up period in patients who underwent radical gastrectomy for stage 2 or 3 gastric cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:

• Patients aged 19 years or more

• Patients who are diagnosed with pathological stage II or III gastric adenocarcinoma according to the AJCC 8th edition

• Patients who can understand all information about the trial and decide for themselves whether to participate in this study

Locations
Other Locations
Republic of Korea
Dongnam Institute of Radiological and Medical Sciences
RECRUITING
Busan
Kosin University Gospel Hospital
NOT_YET_RECRUITING
Busan
Gyeongsang National University Changwon Hospital
RECRUITING
Changwon
Keimyung University Dongsan Hospital
RECRUITING
Daegu
Kyungpook National University Chilgok Hospital
RECRUITING
Daegu
National Cancer Center, Korea
RECRUITING
Goyang-si
Chonnam National University Hwasun Hospital
RECRUITING
Hwasun
Gyeongsang National University Hospital
RECRUITING
Jinju
CHA Bundang Medical Center
RECRUITING
Seongnam
Asan Medical Center
RECRUITING
Seoul
Kangbuk Samsung Hospital
RECRUITING
Seoul
Samsung Medical Center
RECRUITING
Seoul
Seoul National University Hospital
RECRUITING
Seoul
Seoul St. Mary's Hospital
RECRUITING
Seoul
Yonsei Univeristy College of Medicine
RECRUITING
Seoul
Ajou University School of Medicine
RECRUITING
Suwon
Contact Information
Primary
Bang Wool Eom, MD PhD
kneeling79@ncc.re.kr
82-31-920-1689
Time Frame
Start Date: 2021-07-05
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 886
Treatments
Experimental: 3 months follow-up
Patients will be follow-up every 3 months after gastrectomy.
Active_comparator: 6 months follow-up
Patients will be follow-up every 6 months after gastrectomy.
Related Therapeutic Areas
Sponsors
Collaborators: Korea Health Industry Development Institute
Leads: National Cancer Center, Korea

This content was sourced from clinicaltrials.gov